XML 82 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Derivatives and Hedging
6 Months Ended
Jun. 30, 2012
Derivative Instruments and Hedging Activities Disclosure [Text Block]
Derivatives and Hedging
Risk Management Objective and Using Derivatives
The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity and credit risk primarily by managing the amount, sources and duration of its debt funding and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which is determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s investments and borrowings.
Cash Flow Hedges and Interest Rate Risk
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and caps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty if interest rates rise above the strike rate on the contract in exchange for an upfront premium.
On April 11, 2012, the Company entered into a forward starting interest rate swap agreement. This interest rate swap agreement has a notional amount of $100.0 million, a fixed interest rate of 1.13%, and a maturity date of May 11, 2017. On April 27, 2012, the Company entered into a forward starting interest rate swap agreement. This interest rate swap agreement has a notional amount of $50.0 million, a fixed interest rate of 1.06%, and a maturity date of May 11, 2017. In accordance with these agreements, the Company will pay the fixed rate and receive a variable rate based on one-month LIBOR. These interest rate swap agreements became effective on May 11, 2012 upon the execution of a term loan agreement (see Note 13 - "Financing Activities – Senior Unsecured Term Loans").
The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in “Accumulated other comprehensive loss” and is subsequently reclassified into earnings as “Interest expense” as interest payments are made on the Company's variable-rate debt. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings as a “Loss on hedging activities.” The Company reclassified no amounts to "Loss on hedging activities" for the three and six months ended June 30, 2012 and 2011.
Amounts reported in “Accumulated other comprehensive loss” related to derivatives will be reclassified to “Interest expense” as interest payments are made on the Company’s variable-rate debt. Over the next 12 months, the Company expects to reclassify $7.4 million from "Accumulated other comprehensive loss" as an increase to "Interest expense".
As of June 30, 2012, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk ($ in thousands):
Interest Rate Derivative
 
Number of Instruments
 
Notional Amount
Interest Rate Swaps
 
4
 
$400,000


The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the Consolidated Balance Sheets of the Trust and CRLP as of June 30, 2012 and December 31, 2011, respectively.
 
 
Fair Value of Derivative Instruments
 
 
Asset Derivatives
 
Liability Derivatives
 
 
Balance
 
Fair Value at
 
Balance
 
Fair Value at
($ in thousands)
 
Sheet Location
 
6/30/2012
 
12/31/2011
 
Sheet Location
 
6/30/2012
 
12/31/2011
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest Rate Swap
 
Other Assets
 
$

 
$

 
Other Liabilities
 
$
(24,112
)
 
$
(16,619
)


The table below presents the effect of the Company's derivative financial instruments on the Consolidated Statements of Operations and Comprehensive Income (Loss) of the Trust and CRLP for the three and six months ended June 30, 2012 and 2011, respectively.
 
 
Amount of Gain/
 
 
 
Amount of Gain/
 
 
(Loss) Recognized
 
 
 
(Loss) Reclassified
($ in thousands)
 
in OCI on
 
 
 
from OCI
 
 
Derivative
 
 
 
into Income
 
 
(Effective Portion)
 
 
 
(Effective Portion)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Location of Gain/
 
 
 
 
 
 
Derivatives in
 
 
 
 
 
 
 
(Loss) Reclassified
 
 
 
 
 
 
ASC 815 Cash
 
 
 
 
 
 
 
from Accumulated
 
 
 
 
 
 
Flow Hedging
 
Three Months Ended
 
Six Months Ended
 
OCI into Income
 
Three Months Ended
 
Six Months Ended
Relationships
 
6/30/2012
 
6/30/2011
 
6/30/2012
 
6/30/2011
 
(Effective Portion)
 
6/30/2012
 
6/30/2011
 
6/30/2012
 
6/30/2011
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest Rate Swaps
 
$
(10,750
)
 
$
537

 
$
(10,585
)
 
$
537

 
Interest Expense
 
$
(1,800
)
 
$
(120
)
 
$
(3,332
)
 
$
(240
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Credit-Risk-Related Contingent Features
The Company has an agreement with its derivatives counterparty that contains a provision whereby if the Company defaults on any of its indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then the Company could also be declared in default on its derivative obligations.
As of June 30, 2012, the fair value of the derivatives in a net liability position, which includes accrued interest, but excludes any adjustment for nonperformance risk related to this agreement, was $25.6 million. As of June 30, 2012, the Company has not posted any collateral related to this agreement. If the Company had breached any of its provisions at June 30, 2012, it could have been required to settle its obligations under the agreement at its termination value of $25.6 million.